Development and Validation of an Efficient and Highly Sensitive ELISA for Alemtuzumab Quantification in Human Serum and Plasma.
Federica R Achini-GutzwillerCornelia M Jol-van der ZijdeAnja M Jansen-HoogendijkArjan C LankesterRobbert G M BrediusMaarten J D van TolDirk Jan A R MoesMarco W SchilhamPublished in: Therapeutic drug monitoring (2022)
The developed assay provides accurate insight into alemtuzumab exposure and its effects on the clinical response to treatment, which is key to optimizing treatment strategies.